These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10023638)

  • 1. Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance.
    Kuramoto N; Iizuka T; Ito H; Yagui K; Omura M; Nozaki O; Nishikawa T; Tsuchida H; Makino H; Saito Y; Kanatsuka A
    Am J Kidney Dis; 1999 Feb; 33(2):276-81. PubMed ID: 10023638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM.
    Huang XH; Rantalaiho V; Wirta O; Pasternack A; Koivula T; Hiltunen T; Nikkari T; Lehtimäki T
    Hum Genet; 1998 Mar; 102(3):372-8. PubMed ID: 9544854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.
    Huang XH; Rantalaiho V; Wirta O; Pasternack A; Hiltunen TP; Koivula T; Malminiemi K; Nikkari T; Lehtimäki T
    Nephron; 1998 Sep; 80(1):17-24. PubMed ID: 9730698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
    Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
    Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
    Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
    Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy.
    Ha SK; Park HC; Park HS; Kang BS; Lee TH; Hwang HJ; Kim SJ; Kim DH; Kang SW; Choi KH; Lee HY; Han DS
    Am J Kidney Dis; 2003 May; 41(5):943-9. PubMed ID: 12722028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes.
    Miller JA; Scholey JW; Thai K; Pei YP
    Kidney Int; 1997 Jan; 51(1):119-24. PubMed ID: 8995725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy.
    Jeffers BW; Estacio RO; Raynolds MV; Schrier RW
    Kidney Int; 1997 Aug; 52(2):473-7. PubMed ID: 9264004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between ACE gene polymorphism and therapeutic responsiveness of ACEI in diabetic nephropathy].
    Wang L; Pan CY; Hu W
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):372-4. PubMed ID: 10923445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH
    Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics.
    Ohno T; Kawazu S; Tomono S
    Metabolism; 1996 Feb; 45(2):218-22. PubMed ID: 8596493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM.
    Nagi DK; Mansfield MW; Stickland MH; Grant PJ
    Diabet Med; 1995 Nov; 12(11):997-1001. PubMed ID: 8582133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM.
    Fujisawa T; Ikegami H; Shen GQ; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Rakugi H; Higaki J
    Diabetes Care; 1995 Jul; 18(7):983-5. PubMed ID: 7555560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Mizuiri S; Hemmi H; Inoue A; Yoshikawa H; Tanegashima M; Fushimi T; Ishigami M; Amagasaki Y; Ohara T; Shimatake H
    Nephron; 1995; 70(4):455-9. PubMed ID: 7477652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of the angiotensin I-converting enzyme gene in diabetic nephropathy in type II diabetic patients with proliferative retinopathy.
    Hanyu O; Hanawa H; Nakagawa O; Tani N; Andou N; Aizawa Y; Shibata A
    Ren Fail; 1998 Jan; 20(1):125-33. PubMed ID: 9509566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
    Ha SK; Yong Lee S; Su Park H; Ho Shin J; Jung Kim S; Hun Kim D; Rae Kim K; Yung Lee H; Suk Han D
    Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.
    Doi Y; Yoshizumi H; Yoshinari M; Iino K; Yamamoto M; Ichikawa K; Iwase M; Fujishima M
    Diabetologia; 1996 Jan; 39(1):97-102. PubMed ID: 8720609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Boelskifte S; Borch-Johnsen K
    Diabetologia; 1995 Jul; 38(7):798-803. PubMed ID: 7556981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.